Yayınlar & Eserler

Yayın Ağı
Makaleler 13
Tümü (13)
SCI-E, SSCI, AHCI (13)
SCI-E, SSCI, AHCI, ESCI (13)
Scopus (13)

1. Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies

Gauckler P., Matyjek A., Kapsia S., Marinaki S., Quintana L. F., Diaz M. M., et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY , cilt.36, sa.4, ss.668-678, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

2. Biopsy-proven BK virus nephropathy in renal transplant recipients: A multi-central study from Turkey (BK-TURK STUDY)

Gungor O., Dheir H., Islam M., Toz H., YILDIZ A., Sinangil A., et al.
Clinical Nephrology , cilt.102, sa.4, ss.202-211, 2024 (SCI-Expanded) identifier identifier identifier

3. Prognostic factors and validation of the histologic chronicity score for C3 glomerulopathy: a registry analysis

Mirioglu Ş., Cebeci E., Yazici H., DERİCİ Ü., Sahin G., ÇOBAN G., et al.
CLINICAL KIDNEY JOURNAL , cilt.17, sa.8, 2024 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

4. Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group

Mirioglu Ş., Daniel-Fischer L., Berke I., Ahmad S. H., Bajema I. M., Bruchfeld A., et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.39, sa.4, ss.569-580, 2024 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

5. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

Vart P., Duivenvoorden R., Adema A., Covic A., Finne P., Braak N. H., et al.
Scientific Reports , cilt.12, sa.1, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

6. Clinical and pathologic features of primary membranous nephropathy in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group

YILDIZ A., Ulu S., ORUÇ A., Ucar A. R., Ozturk S., Alagoz S., et al.
RENAL FAILURE , cilt.44, sa.1, ss.1048-1059, 2022 (SCI-Expanded) identifier identifier identifier

7. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

Hemmelder M. H., Noordzij M., Vart P., Hilbrands L. B., Jager K. J., Abrahams A. C., et al.
Nephrology Dialysis Transplantation , cilt.37, sa.6, ss.1140-1151, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

8. Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months After a Diagnosis of COVID-19

Duivenvoorden R., Vart P., Noordzij M., Soares dos Santos A. C., Zulkarnaev A. B., Franssen C. F. M., et al.
TRANSPLANTATION , cilt.106, sa.5, ss.1012-1023, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

9. Ambulatory blood pressure monitoring: from old concepts to novel insights

Kanbay M., Turkmen K., Ecder T., Covic A.
INTERNATIONAL UROLOGY AND NEPHROLOGY , cilt.44, sa.1, ss.173-182, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

10. Assessment of Adrenal Functions in Patients with Autosomal Dominant Polycystic Kidney Disease

Tufan F., USLU B., CEKREZI B., UYSAL M., ALPAY N., TURKMEN K., et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.118, sa.10, ss.741-746, 2010 (SCI-Expanded) identifier identifier identifier

11. Improvement of Coronary Flow Velocity Reserve with Telmisartan in Patients with Autosomal-Dominant Polycystic Kidney Disease

Alisir S., Turkmen K., Alpay N., Elitok A., Oflaz H., Uslu B., et al.
SOUTHERN MEDICAL JOURNAL , cilt.103, sa.5, ss.409-413, 2010 (SCI-Expanded) identifier identifier identifier

12. Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: From impaired tubules to impaired carotid and coronary arteries

Turkmen K., Oflaz H., Uslu B., Cimen A. O., Elitok A., Kasikcioglu E., et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY , cilt.3, sa.4, ss.986-991, 2008 (SCI-Expanded) identifier identifier identifier

13. Coronary flow reserve after L-thyroxine therapy in Hashimoto's thyroiditis patients with subclinical and overt hypothyroidism

Oflaz H., Kurt R., Sen F., Onur I., Cimen A. O., Elitok A., et al.
Endocrine , cilt.32, sa.3, ss.264-270, 2007 (SCI-Expanded) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 6

1. IMMUNOSUPPRESSIVE TREATMENT RESULTS IN PATIENTS WITH PRIMARY IGA NEPHROPATHY IN TURKIYE: A NATIONWIDE STUDY

ORUÇ A., ŞUMNU A., Turkmen A., Basturk T., Cebeci E., TURGUTALP K., et al.
60th ERA Congress, Milan, İtalya, 15 - 18 Haziran 2023, (Özet Bildiri) identifier

2. COULD MESANGIAL C3 DEPOSITION BE AN INDEPENDENT PROGNOSTIC MARKER IN IMMUNOGLOBULIN A NEPHROPATHY?

Cetinkaya H., GÜRSU M., YAZICI H., Cebeci E., EREN N., ALTIPARMAK M. R., et al.
60th ERA Congress, Milan, İtalya, 15 - 18 Haziran 2023, (Özet Bildiri) identifier

3. THE EFFECT OF GLOMERULAR C3 DEPOSITION ON RENAL OUTCOME IN PATIENTS WITH MEMBRANOUS NEPHROPATHY: DATA OF THE TSN-GOLD STUDY

GÜRSU M., Ceheci E., Turkmen A., DERVİŞOĞLU E., Sezen M., TURGUTALP K., et al.
60th ERA Congress, Milan, İtalya, 15 - 18 Haziran 2023, (Özet Bildiri) identifier

4. ASSOCIATION OF MULTIPLE PLASMA BIOMARKER LEVELS WITH KIDNEY DISEASE ACTIVITY IN FABRY DISEASE

ÖZCAN SOYSAL Ş. G., Atli Z., EREN N., DİNÇER M. T., Turkmen K., Ozer H., et al.
60th ERA Congress, Milan, İtalya, 15 - 18 Haziran 2023, (Özet Bildiri) identifier

5. PROGNOSTIC FACTORS AND VALIDATION OF THE HISTOLOGIC CHRONICITY SCORE FOR C3 GLOMERULOPATHY: A REGISTRY ANALYSIS

Mirioglu Ş., Cebeci E., YAZICI H., DERİCİ Ü., Sahin G. M., EREN N., et al.
60th ERA Congress, Milan, İtalya, 15 - 18 Haziran 2023, (Özet Bildiri) identifier

6. EPIDEMIOLOGICAL AND CLINICAL CHARACTERSTICS OF IGA NEPHROPATHY PATIENTS IN TURKEY: TSN-GOLD WORKING GROUP

EREN N., GÜRSU M., Cebeci E., Turkmen A., YETER H. H., SEYAHİ N., et al.
57th ERA-EDTA Congress, ELECTR NETWORK, 6 - 09 Haziran 2020, cilt.35, ss.749, (Özet Bildiri) identifier
Metrikler

Yayın

19

Yayın (WoS)

19

Yayın (Scopus)

13

Atıf (WoS)

110

H-İndeks (WoS)

6

Atıf (Scopus)

116

H-İndeks (Scopus)

6

Açık Erişim

4
BM Sürdürülebilir Kalkınma Amaçları